These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8951676

  • 1. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA, Xu SX, Yanni JM.
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [Abstract] [Full Text] [Related]

  • 3. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Sep; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 4. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
    Sharif NA, Su SX, Yanni JM.
    J Ocul Pharmacol; 1994 Sep; 10(4):653-64. PubMed ID: 7714409
    [Abstract] [Full Text] [Related]

  • 5. Ophthalmic antihistamines and H1-H4 receptors.
    Wade L, Bielory L, Rudner S.
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):510-6. PubMed ID: 22918191
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA, Wiernas TK, Griffin BW, Davis TL.
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
    Ohmori K, Hasegawa K, Tamura T, Miyake K, Matsubara M, Masaki S, Karasawa A, Urayama N, Horikoshi K, Kajita J, Hasegawa M, Taniguchi K, Komada T, Kawamoto Y.
    Arzneimittelforschung; 2004 Nov; 54(12):809-29. PubMed ID: 15646365
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
    Yanni JM, Miller ST, Gamache DA, Spellman JM, Xu S, Sharif NA.
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):541-5. PubMed ID: 9433371
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H, Ohashi Y, Takamura E.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [Abstract] [Full Text] [Related]

  • 11. A current appreciation of sites for pharmacological intervention in allergic conjunctivitis: effects of new topical ocular drugs.
    Yanni JM, Sharif NA, Gamache DA, Miller ST, Weimer LK, Spellman JM.
    Acta Ophthalmol Scand Suppl; 1999 Oct; (228):33-7. PubMed ID: 10337430
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M, Berger WE, Butrus S, Epstein AB, Irkec M.
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [Abstract] [Full Text] [Related]

  • 13. Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: role in ocular allergic and inflammatory diseases.
    Sharif NA, Xu SX, Magnino PE, Pang IH.
    Exp Eye Res; 1996 Aug; 63(2):169-78. PubMed ID: 8983974
    [Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J, Schoemaker H, Dana C, Claustre Y, Delahaye M, Prouteau M, Manoury P, Allen J, Scatton B, Langer SZ.
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [Abstract] [Full Text] [Related]

  • 15. A review of the use of olopatadine in allergic conjunctivitis.
    McGill JI.
    Int Ophthalmol; 2004 May; 25(3):171-9. PubMed ID: 15847317
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
    Ohmori K, Hayashi K, Kaise T, Ohshima E, Kobayashi S, Yamazaki T, Mukouyama A.
    Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
    [Abstract] [Full Text] [Related]

  • 17. Ocular allergy treatment comparisons: azelastine and olopatadine.
    Bielory L, Buddiga P, Bigelson S.
    Curr Allergy Asthma Rep; 2004 Jul; 4(4):320-5. PubMed ID: 15175148
    [Abstract] [Full Text] [Related]

  • 18. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A, Quintieri L.
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [Abstract] [Full Text] [Related]

  • 19. A review of olopatadine for the treatment of ocular allergy.
    Abelson MB.
    Expert Opin Pharmacother; 2004 Sep; 5(9):1979-94. PubMed ID: 15330735
    [Abstract] [Full Text] [Related]

  • 20. [Olopatadine].
    Taéron C.
    Rev Infirm; 2004 Apr; (100):43-4. PubMed ID: 15222186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.